Angel Studios
ANGX
3.98
-0.09
-2.21%
Angel Studios
US · ANGX
#3445 by market cap
Listed 2022
3.98
-0.09
-2.21%
Live - 5344 symbols - heartbeat 105s ago
· 2026-10-09 20:02
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -1.06, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 4 years
Latest year +233.16% YoY
Margins
- Gross margin
- 61.17%
- Operating margin
- -51.04%
- Net margin
- -53.02%
Key ratios & quality
- Enterprise valuei
- 797.66M
- Altman Z-Scorei
- -1.06
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 75.52M | 202.44M | 96.52M | 321.56M |
| Gross profit | 35.12M | 116.40M | 52.16M | 196.70M |
| Selling & admin expenses | 32.11M | 94.34M | 126.03M | 345.28M |
| Research & development | 12.35M | 9.70M | 12.84M | 15.53M |
| Operating profit | -9.33M | 12.36M | -86.72M | -164.11M |
| Pretax profit | -14.48M | 10.52M | -84.91M | -170.49M |
| Tax | -765.19K | -2.70M | 3.53M | 0 |
| Net profit | -13.71M | 13.21M | -88.45M | -170.49M |
| Basic EPS | 0 | 0 | -1 | -1 |
| Diluted EPS | -0.09 | 0.08 | -0.55 | -1.10 |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 31.03M | 47.44M | 87.64M | 109.93M | 115.11M | 111.71M |
| Gross profit | 18.01M | 27.96M | 60.36M | 66.18M | 71.10M | 59.96M |
| Selling & admin expenses | 45.13M | 58.31M | 78.04M | 132.85M | 69.68M | 74.47M |
| Research & development | 1.64M | 3.24M | 3.64M | 4.20M | 4.08M | 4.00M |
| Operating profit | -28.76M | -33.59M | -21.32M | -70.88M | -2.67M | -18.51M |
| Pretax profit | -29.16M | -37.33M | -15.71M | -78.62M | -13.76M | -23.79M |
| Tax | 8.02M | 0 | 0 | 0 | 0 | 0 |
| Net profit | -37.18M | -37.33M | -15.71M | -78.62M | -13.76M | -23.79M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.23 | -0.23 | -0.10 | -0.47 | -0.08 | -0.13 |
Balance sheet
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total current assets | 22.22M | 65.06M | 52.95M | 134.88M |
| Cash & ST investments | 10.72M | 25.20M | 7.21M | 44.08M |
| Inventory | 500.68K | 2.84M | 1.71M | 1.26M |
| Total assets | 39.39M | 98.26M | 111.38M | 241.41M |
| Total current liabilities | 11.43M | 44.12M | 80.06M | 219.00M |
| Short-term debt | 2.65M | 4.52M | 12.13M | 56.76M |
| Long-term debt | -- | -- | -- | 41.69M |
| Total liabilities | 17,386,196.00 | 58,582,535.00 | 94,672,613.00 | 267,191,887.00 |
| Total equity | 22.00M | 39.68M | 16.71M | -25.78M |
| Retained earnings | -19.24M | -10.07M | -87.01M | -241.53M |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 52.95M | 82.66M | 109.13M | 134.88M | 111.62M | 125.35M |
| Cash & ST investments | 7.21M | 14.19M | 28.00M | 44.08M | 38.88M | 48.04M |
| Inventory | 1.71M | 1.61M | 1.47M | 1.26M | 1.38M | 1.48M |
| Total assets | 111.38M | 118.58M | 148.09M | 241.41M | 213.09M | 235.06M |
| Total current liabilities | 80.06M | 106.77M | 123.69M | 219.00M | 188.16M | 192.52M |
| Short-term debt | 12.13M | 22.86M | 30.42M | 56.76M | 41.79M | 18.55M |
| Long-term debt | -- | 3.41M | 5.77M | 41.69M | 61.80M | 57.17M |
| Total liabilities | 94,672,613.00 | 124,538,346.00 | 140,299,550.00 | 267,191,887.00 | 254,545,158.00 | 264,391,901.00 |
| Total equity | 16.71M | -5.96M | 7.79M | -25.78M | -41.46M | -29.33M |
| Retained earnings | -87.01M | -121.33M | -137.21M | -241.53M | -255.34M | -279.13M |
Cash flow
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | -11.66M | 15.19M | -51.30M | -83.33M |
| Depreciation & amortization | 1.12M | 6.35M | 8.58M | 15.34M |
| Free cash flow | -12.80M | 5.34M | -60.54M | -101.89M |
| Dividends paid | -- | -- | -- | -- |
| Stock buybacks / issuance | -427.22K | 7.39M | 32.11M | 103.71M |
| Ending cash balance | 10.72M | 25.20M | 7.21M | 44.08M |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -11.21M | -9.76M | -10.59M | -- | 1.89M | 16.94M |
| Depreciation & amortization | 7.30M | 2.46M | 2.45M | -- | 3.95M | 3.94M |
| Free cash flow | -20.18M | -12.25M | -16.85M | -- | -806.49K | 13.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 5.81M | 14.73M | 23.64M | -- | -897.42K | 34.27M |
| Ending cash balance | 7.21M | 14.19M | 28.00M | -- | 38.88M | 48.04M |
Returns & efficiency
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| ROE %i | -62.32 | 29.64 | -506.52 | -- |
| ROA %i | -34.81 | 13.32 | -91.26 | -100.30 |
| ROIC %i | -52.47 | 29.78 | -328.42 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -18.25 | 4.93 | -87.10 | -49.34 |
| FCF / sales %i | -- | 2.58 | -- | -- |
| Current ratioi | 1.94 | 1.47 | 0.66 | 0.62 |
| Quick ratioi | 1.76 | 1.31 | 0.53 | 0.49 |
| Debt / assetsi | 10.11 | 5.58 | 12.82 | 41.63 |
| LT debt / equityi | 6.05 | 2.41 | 25.38 | -- |
| Interest coveragei | -19.85 | 2.73 | -35.53 | -13.41 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 62.08 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -506.52 | -- | -1,380.46 | -- | -- | -- |
| ROA %i | -91.26 | -94.76 | -95.35 | -100.30 | -88.63 | -80.91 |
| ROIC %i | -328.42 | -- | -349.71 | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -87.10 | -87.97 | -49.81 | -49.34 | -33.56 | -33.48 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.66 | 0.77 | 0.88 | 0.62 | 0.59 | 0.65 |
| Quick ratioi | 0.53 | 0.63 | 0.79 | 0.49 | 0.43 | 0.46 |
| Debt / assetsi | 12.82 | 23.81 | 25.70 | 41.63 | 49.42 | 32.79 |
| LT debt / equityi | 25.38 | -- | 258.77 | -- | -- | -- |
| Interest coveragei | -35.53 | -30.15 | -17.99 | -13.41 | -8.01 | -8.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Angel Studios discussion 0 comments